Open-Label Extension of LOCKCYST Trial

Polycystic liver disease

Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease Open-Label Extension of LOCKCYST Trial Octreotide in Severe Polycystic Liver Disease Pasireotide LAR in Severe Polycystic Liver Disease Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE) Everolimus and LongActing Octreotide Trial in Polycystic Livers Lanreotide as Treatment of Polycystic Livers Automatic Segmentation of Polycystic Liver Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease Lanreotide Autogel in the Treatment of Symptomatic Polycystic Liver Disease Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q). Polycystic Liver Disease in Kidney Transplant